How to treat Urticaria?

['Yingisela tluka leri']

Xana u nga wu tshungula njhani vuvabyi bya swirhumbana?

Urticaria, leyi tivekaka tanihi swirhumbana, i xiyimo xa nhlonge lexi vonakaka hi ku va ni swirhumbana leswi nga ni swirhumbana, leswi nga ha humelelaka eka xiphemu xihi na xihi xa miri.

Swi nga ha vangiwa hi swilo swo hambana-hambana, ku katsa ni ku va munhu a vabya, mavabyi kumbe mavabyi man'wana.

Vutshunguri bya urticaria byi titshege hi ndlela leyi byi nga ni khombo ha yona ni xivangelo xa kona.

Hi leti tindlela tin'wana leti tolovelekeke to tshungula:

1. Mirhi leyi lwaka ni ku pfimba ka marhambu: Mirhi leyi yi pfuna ku hunguta ku pandza ni ku pfimba hi ku sivela histamine, ku nga khemikhali leyi humesiwaka hi miri loko miri wu va ni swirhumbana.

Mirhi leyi nga xavisiwiki leyi vuriwaka antihistamines yo tanihi diphenhydramine (Benadryl) kumbe loratadine (Claritin) yi nga pfuna eka mavabyi yo olova.

Eka vanhu lava nga ni vuvabyi lebyi nga ni khombo swinene, dokodela a nga ha va nyika mirhi leyi nga ni matimba swinene yo lwa ni switsongwatsongwana swa histamine.

2. Corticosteroids: Loko mirhi leyi lwaka ni switsongwatsongwana swa histamine yi nga tirhi, ku nga ha tirhisiwa mirhi leyi lwaka ni switsongwatsongwana swa miri yo tanihi prednisone leswaku ku hungutiwa ku pfimba ni ku sivela fambiselo ra nsawutiso.

Mirhi leyi hi ntolovelo yi nwiwa hi nomu naswona yi nga pfuna hi ku hatlisa.

3. Mirhi leyi sivelaka nsawutiso: Eka vanhu lava nga ni vuvabyi lebyi nga tshungulekiki, mirhi yo tanihi cyclosporine kumbe methotrexate yi nga ha tirhisiwa ku sivela nsawutiso ni ku hunguta ku pfimba.

4. Omalizumab: Murhi lowu i murhi lowu tlhaveriwaka hi nayiti lowu nga ni nsawutiso lowu hlaselaka ni ku sivela tiphroteyini leti vuriwaka immunoglobulin E (IgE), leti katsekaka eka ku va munhu a va ni switsongwatsongwana.

Hi xitalo yi tirhisiwa eka vuvabyi bya xitsongwatsongwana lebyi nga hlamuliki eka vutshunguri byin'wana.

5. Papalata swilo leswi vangaka vuvabyi lebyi: Ku tiva ni ku papalata swilo leswi vangaka vuvabyi lebyi swi nga pfuna ku sivela ku hangalaka ka byona.

Swakudya swin'wana, mirhi, ku lumiwa hi switsotswana, ku hisa, xirhami kumbe ku tlhaviwa hi dyambu swi nga ha ku vangela vuvabyi lebyi.

6. Ku tirhisa nchumu wo titimela: Ku tirhisa nchumu wo titimela endhawini leyi nga ni swirhumbana swi nga pfuna ku hunguta ku pandza ni ku pfimba.

7. Ku phutsela hi mati: Ku phutsela hi mati swi nga ha tirhisiwa ku hunguta ku pandza ni ku hunguta ku pfimba.

Ndhawu leyi nga ni vuvabyi yi tsondzeriwa hi lapi leri tsakameke ivi ku tlhandlekiwa lapi leri omeke leswaku ri nga tsakamisi.

8. Vutshunguri bya ku voninga: Ku voningeriwa hi miseve ya ultraviolet swi nga pfuna ku hunguta fambiselo ra nsawutiso ni ku hunguta ku pfimba eka vanhu van'wana lava nga ni vuvabyi lebyi nga tshungulekiki bya swirhumbana.

I swa nkoka ku vonana ni dokodela leswaku a ta kota ku vona vuvabyi lebyi ni ku byi tshungula.

Va nga ku pfuna leswaku u tiva xivangelo xa kona ni ku ku byela vutshunguri lebyi faneleke.

['Tinhlamuselo']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Deleanu D, Nedelea I, Petricau C, Leru P, Dumitrascu D, Muntean A: Clinical impact of omalizumab in refractory chronic urticaria: One centre experience. Exp Ther Med. 2019, 18 (6): 5078-5081.

Grundmann SA, Kiefer S, Luger TA, Brehler R: Delayed pressure urticaria - dapsone heading for first-line therapy? J Dtsch Dermatol Ges. 2011, 9 (11): 908-12.

Staumont-Sallé D, Piette F, Delaporte E: [Etiological diagnosis and treatment of chronic urticaria]. Rev Med Interne. 2003, 24 (1): 34-44.

Akashi R, Ishiguro N, Shimizu S, Kawashima M: Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol. 2011, 38 (8): 761-6.

Calogiuri G, Nettis E, Mandurino-Mirizzi A, Di Leo E, Macchia L, Foti C, Vacca A, Kounis NG: Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report. Antiinflamm Antiallergy Agents Med Chem. 2020, 19 (3): 335-339.

['Xihlambanyo xa vutihlamuleri: swa vutshunguri']

['Website leyi yi endleriwe ku dyondzisa ni ku nyika rungula ntsena naswona a yi nyiki switsundzuxo swa vutshunguri kumbe mintirho ya vativi va swa vutshunguri.']

['Rungula leri nyikeriweke a ri fanelanga ri tirhisiwa ku kambela kumbe ku tshungula xiphiqo xa rihanyo kumbe vuvabyi, naswona lava lavaka xitsundzuxo xa vutshunguri va fanele va vonana ni dokodela la nga ni mpfumelelo.']

['Xiya leswaku ndlela leyi ti-neural net ti hlamulaka swivutiso ha yona a yi pakanisi ngopfu loko ku vulavuriwa hi tinomboro, to tanihi nhlayo ya vanhu lava khomiweke hi vuvabyi byo karhi.']

["Minkarhi hinkwayo kombela xitsundzuxo eka dokodela wa wena kumbe eka muongori la fanelekaka malunghana ni xiyimo xa rihanyo ra wena. U nga tshuki u honisa xitsundzuxo xa dokodela kumbe u hlwela ku xi lava hikwalaho ka leswi u swi hlayeke eka website leyi. Loko u ehleketa leswaku u le xiyin'weni xa xihatla xa rihanyo, bela riqingho eka 911 kumbe u ya ekamareni ra xihatla leri nga ekusuhi na wena hi ku hatlisa. A ku na vuxaka bya dokodela ni muvabyi lebyi tumbuluxiweke hi website leyi kumbe ku tirhisiwa ka yona. BioMedLib kumbe vatirhi va yona, kumbe un'wana ni un'wana la hoxaka xandla eka website leyi, a nga endli switiyisekiso, leswi nga erivaleni kumbe leswi nga erivaleni, malunghana ni rungula leri nga laha kumbe ku tirhisiwa ka rona."]

['Ku ala ku byarha vutihlamuleri: mfanelo yo tsala']

['Nawu wa Digital Millennium Copyright Act wa 1998, 17 U.S.C. § 512 (DMCA) wu nyika tindlela ta ku tihlanganisa na vini va timfanelo ta vuhleri lava va tshembaka leswaku swilo leswi humelelaka eka Internet swi tlula timfanelo ta vona ehansi ka nawu wa vuhleri wa U.S.']

['Loko u tshemba leswaku rungula kumbe swilo leswi kumekaka eka website ya hina kumbe eka mintirho ya hina swi tlula mfanelo ya wena yo endla swilo, wena (kumbe muyimeri wa wena) u nga hi rhumela xitiviso u kombela leswaku rungula kumbe swilo leswi swi susiwa kumbe swi siveriwa.']

['Switiviso swi fanele ku rhumeriwa hi ku tsala hi imeyili (languta eka xiyenge xa "Vuxaka" eka adirese ya imeyili).']

["DMCA yi lava leswaku xitiviso xa wena xa ku tlula nawu wa mfanelo ya ku tsala xi katsa mahungu lawa landzelaka: (1) nhlamuselo ya ntirho lowu nga na mfanelo ya ku tsala lowu ku vuriwaka leswaku wu tluriwile; (2) nhlamuselo ya leswi ku vuriwaka leswaku swi tlula nawu wa ku tsala ni mahungu lama ringaneke ku hi pfumelela ku kuma leswi nga endzeni; (3) mahungu ya ku tihlanganisa na wena, ku katsa ni adirese ya wena, nomboro ya riqingho na adirese ya imeyili; (4) xitiviso xa wena xa leswaku u ni ripfumelo ra leswaku leswi nga endzeni hi ndlela leyi ku vilelaka ha yona a swi pfumeleriwanga hi n'wini wa mfanelo ya ku tsala, kumbe muyimeri wa yena, kumbe hi ku tirha ka nawu wihi na wihi; "]

['(5) xitiyisiso xa wena, lexi sayiniweke ehansi ka nxupulo wa ku hemba, xa leswaku mahungu lama nga eka xitiviso i ntiyiso ni leswaku u na matimba yo tirhisa timfanelo ta vuqambi leti ku vuriwaka leswaku ti tluriwile;']

["na (6) ku sayina ka xiviri kumbe ka elektroniki ka n'wini wa mfanelo ya vuqambi kumbe munhu la pfumeleriweke ku endla hi vito ra n'wini wa mfanelo ya vuqambi. "]

['Loko u nga nghenisi vuxokoxoko hinkwabyo lebyi nga laha henhla swi nga endla leswaku ku tirhana ni xivilelo xa wena swi hlwela.']

['Ku Tihlanganisa']

['Hi kombela u hi rhumela imeyili hi xivutiso/xiringanyeto xihi na xihi.']

How to treat urticaria?

Urticaria, commonly known as hives, is a skin condition characterized by itchy, raised welts that can appear on any part of the body.

It can be caused by various factors, including allergic reactions, infections, or underlying medical conditions.

Treatment for urticaria depends on the severity of the condition and the underlying cause.

Here are some common treatment options:

1. Antihistamines: These medications help to reduce itching and swelling by blocking the effects of histamine, a chemical released by the body during an allergic reaction.

Over-the-counter antihistamines such as diphenhydramine (Benadryl) or loratadine (Claritin) can be effective in mild cases.

In more severe cases, a doctor may prescribe stronger antihistamines.

2. Corticosteroids: In cases where antihistamines are not effective, corticosteroids such as prednisone may be prescribed to reduce inflammation and suppress the immune system.

These medications are usually taken orally and can provide quick relief.

3. Immunosuppressants: In cases of chronic urticaria that do not respond to other treatments, immunosuppressant drugs such as cyclosporine or methotrexate may be prescribed to suppress the immune system and reduce inflammation.

4. Omalizumab: This medication is an injectable monoclonal antibody that targets and blocks immunoglobulin E (IgE), a protein involved in allergic reactions.

It is typically used for chronic urticaria that does not respond to other treatments.

5. Avoid triggers: Identifying and avoiding triggers that cause urticaria can help prevent outbreaks.

Common triggers include certain foods, medications, insect bites, and exposure to heat, cold, or sunlight.

6. Cold compress: Applying a cold compress to the affected area can help reduce itching and swelling.

7. Wet wraps: Wet wraps can be used to soothe itching and reduce inflammation.

A damp cloth is wrapped around the affected area, and then a dry cloth is placed over it to retain moisture.

8. Phototherapy: Exposure to ultraviolet light can help suppress the immune system and reduce inflammation in some cases of chronic urticaria.

It is important to consult a healthcare professional for proper diagnosis and treatment of urticaria.

They can help determine the underlying cause and recommend the most appropriate treatment plan.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.